Investor Presentaiton

3 Experienced Board and Management Team Robert Taub Founder, Chairman Olivier Taelman Chief Executive Officer Loïc Moreau Chief Financial Officer Serial entrepreneur in the pharmaceutical and medical fields Co-founded and co-managed Octapharma - Human plasma protein company Founded and managed Omrix Biopharmaceuticals - NASDAQ IPO, followed by the acquisition by J&J Early investor and chairman of Neuroderm, a Parkinson's disease pharmaceutical company - IPO on NASDAQ and later sale to Mitsubishi-Tanabe • Experienced Medtech leader 7 years in pharmaceutical healthcare at Eli Lilly and Sanofi Aventis leading specific Business Units 18 years within the field of Medtech neuromodulation at Medtronic, managing EMEA at Stryker NeuroVascular and serving a neuromodulation company Nevro where he was responsible for building the European business during the successful NASDAQ IPO Joined Nyxoah in July 2019 as Chief Operating and Commercial Officer, subsequently being appointed as CEO in November 2019. . Experienced Finance leader 13 years in Pharmaceutical healthcare at GSK with roles in Corporate Development/M&A (UK), Finance R&D (UK) or Country CFO where he notably led and structured the various support functions for GSK business in France (€1bn+ turnover) Started his career at EY (external audit) followed by PwC (Corporate Finance) Joined Nyxoah in 2022 to take the leadership of the finance department. Nyxoah

View entire presentation